Janux Therapeutics, Inc. (JANX) Operating margin 2021–2025
Janux Therapeutics, Inc. (JANX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1576.7%FY2025 · since FY2021: -905.4% → -1576.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1576.7% | -643.1 pp |
| FY2024 | -933.6% | -30.7 pp |
| FY2023 | -902.9% | -123.8 pp |
| FY2022 | -779.0% | +126.3 pp |
| FY2021 | -905.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice